0548-8352 : Baqsimi 3 mg Nasal Powder


NDC: 0548-8352
Labeler: Amphastar Pharmaceuticals, Inc.
Product Type: Human Prescription Drug
Drug Name:  Baqsimi
Dosage Form: Nasal Powder
Application #: NDA210134
Rev. Date: 


NDC Package Codes:

  • 0548-8352-02: 2 TUBE IN 1 CARTON (0548‑8352‑02) / 1 BOTTLE, UNIT‑DOSE IN 1 TUBE / 1 POWDER IN 1 BOTTLE, UNIT‑DOSE

Active Ingredients:

  • Glucagon

Dosage Strength:

  • 3 mg

Pharmaceutical Classes:

  • Antihypoglycemic Agent [EPC]
  • Decreased GI Motility [PE]
  • Decreased GI Smooth Muscle Tone [PE]
  • Decreased Glycolysis [PE]
  • Gastrointestinal Motility Inhibitor [EPC]
  • Increased Gluconeogenesis [PE]
  • Increased Glycogenolysis [PE]

Related Products:

Based on records with the same trade name.
  • 0548-8351 Baqsimi 3 mg Nasal Powder by Amphastar Pharmaceuticals, Inc.
  • 0002-6145 Baqsimi 3 mg Nasal Powder by Eli Lilly and Company

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 0548-8352 QR Code

< Prev: 0548-8351Next: 0548-9021 >




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.